|
gptkbp:instance_of
|
gptkb:diabetes
|
|
gptkbp:administered_by
|
injection
|
|
gptkbp:approves
|
gptkb:FDA
|
|
gptkbp:are
|
oral medications
cures for diabetes
|
|
gptkbp:are_part_of
|
insulin therapy
personalized medicine approaches
diabetes care plans
|
|
gptkbp:available_in
|
gptkb:gasoline
gptkb:PEN_International
various formulations
vial
various strengths
|
|
gptkbp:can_be_administered_in
|
hospital settings
|
|
gptkbp:can_be_administered_with
|
gptkb:breakfast
|
|
gptkbp:can_be_combined_with
|
lifestyle changes
oral hypoglycemics
|
|
gptkbp:can_be_used_in
|
gestational diabetes
|
|
gptkbp:can_be_used_to
|
manage postprandial glucose spikes
prevent ketoacidosis
|
|
gptkbp:can_be_used_with
|
continuous glucose monitors
|
|
gptkbp:can_cause
|
allergic reactions
|
|
gptkbp:developed_by
|
gptkb:biotechnology
pharmaceutical companies
late 20th century
|
|
gptkbp:has_impact_on
|
blood glucose levels
|
|
gptkbp:has_variations
|
peak times
duration of action
onset times
|
|
gptkbp:have_advantage_over
|
gptkb:regular_insulin
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
insulin analogs
|
|
gptkbp:improves
|
glycemic control
|
|
gptkbp:include
|
gptkb:insulin_lispro
gptkb:insulin_aspart
gptkb:insulin_degludec
gptkb:insulin_detemir
gptkb:insulin_glulisine
|
|
gptkbp:influence
|
insulin sensitivity
|
|
gptkbp:is_compared_to
|
gptkb:regular_insulin
|
|
gptkbp:is_considered
|
essential medicines
modern treatment options
|
|
gptkbp:is_evaluated_by
|
clinical trials
efficacy and safety
|
|
gptkbp:is_recommended_by
|
gptkb:healthcare_professionals
|
|
gptkbp:is_recommended_for
|
intensive insulin therapy
|
|
gptkbp:is_subject_to
|
gptkb:guidelines
regulatory approval
insurance coverage
|
|
gptkbp:is_used_by
|
diabetes patients
|
|
gptkbp:is_used_to
|
achieve target A1 C levels
|
|
gptkbp:reduce_risk_of
|
diabetes complications
|
|
gptkbp:require_monitoring_of
|
blood sugar levels
|
|
gptkbp:requires
|
prescription
|
|
gptkbp:side_effect
|
weight gain
hypoglycemia
|
|
gptkbp:stored_at
|
room temperature
|
|
gptkbp:type
|
synthetic insulin
|
|
gptkbp:used_for
|
diabetes management
|
|
gptkbp:used_in
|
type 2 diabetes
type 1 diabetes
|
|
gptkbp:bfsParent
|
gptkb:Humalog
|
|
gptkbp:bfsLayer
|
5
|